0000000000064349

AUTHOR

Roberta Alaimo

showing 4 related works from this author

Incidence of onychomycosis among psoriatic patients with nail involvement: a descriptive study

2013

AdultMalemedicine.medical_specialtyAdolescentMEDLINEonychomycosis PSORIASIS NAILSDermatologyYoung AdultOnychomycosisHumansPsoriasisMedicineYoung adultAgedbusiness.industryIncidenceIncidence (epidemiology)General MedicineMiddle AgedDermatologyInfectious Diseasesmedicine.anatomical_structureNailsNail (anatomy)FemaleDescriptive researchbusinessMycoses
researchProduct

Pseudochromhidrosis: the role of dermoscopy in diagnosis

2014

medicine.medical_specialtybusiness.industryPseudochromhidrosisSettore MED/35 - Malattie Cutanee E VenereemedicineDermatologybusinessDermatologyPseudochromhidrosisInternational Journal of Dermatology
researchProduct

Gender differences in adverse drug reactions in dermatological patients in west Sicily: an epidemiological study

2013

Purpose: The purpose of this study was to show that gender also plays an important role in pharmacokinetics, pharmacodynamics, and drug toxicity. It is only fair to take into account the so-called “gender-based medicine.” Methods: We again selected admission for cutaneous adverse drug reaction (CADRs), from January 2012 to July 2012, in order to detect and verify, in an analytical way, the substantial gender differences in adverse drug reactions in term incidence, clinical manifestations, severity and drugs involved. Results:In the period January–July 2012, at the Department of Dermatology and Sexually Transmitted Disease of A.O.U.P. “Paolo Giaccone” Palermo, 384 patients were admitted, of …

AdultMaleSexually transmitted diseasemedicine.medical_specialtyDermatologyPharmacologySex FactorsPharmacokineticsInternal medicineEpidemiologyPharmacovigilancemedicineSettore MED/35 - Malattie Cutanee E VenereeHumansSicilyRetrospective Studiesbusiness.industryIncidenceIncidence (epidemiology)Retrospective cohort studyadverse drug reactions gender-based medicine pharmacovigilanceMiddle Agedmedicine.diseasePharmacodynamicsFemaleDrug EruptionsbusinessAdverse drug reaction
researchProduct

Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.

2014

What is known and objective: Pemphigus is a severe, potentially life-threatening autoimmune blistering disease. The use of corticosteroids has dramatically improved the prognosis and changed its course. However, current morbidity of pemphigus is largely iatrogenic, caused by side effects of the long-term, high-dose corticosteroid therapy that is necessary to sustain disease control. In order to minimize side effects, a range of corticosteroid-sparing immunosuppressive agents have been introduced, including mycophenolate mofetil (MMF) and enteric-coated mycophenolate sodium (EC-MPS). A systematic review was performed to evaluate the effectiveness of MMF and EC-MPS in the treatment of pemphig…

medicine.medical_specialtyEnteric-coated mycophenolate sodium mycophenolate mofetil mycophenolic acid pemphigus foliaceus pemphigus vulgaris therapyDermatologyMycophenolateMycophenolic acidimmune system diseasesmedicineSettore MED/35 - Malattie Cutanee E VenereeHumansEnteric coatedskin and connective tissue diseasesGlucocorticoidsPemphigus foliaceusintegumentary systembusiness.industryPemphigus vulgarisMycophenolate SodiumMycophenolic AcidPrognosismedicine.diseaseDermatologyPemphigusTreatment OutcomeDrug Therapy CombinationDermatologic AgentsbusinessImmunosuppressive AgentsPemphigusmedicine.drugBlistering disease
researchProduct